Dominic Nicholas Jackson
Directeur/Membre du Conseil chez Redx Oncology Ltd.
Profil
Dominic Nicholas Jackson is currently a Director at Redx Oncology Ltd.
and a Member at The Chartered Institute For Securities & Investment.
Previously, he worked as the Chief Financial Officer & Executive Director at Redx Pharma Plc from 2017 to 2019.
He also worked as a Member at the Institute for Turnaround.
Postes actifs de Dominic Nicholas Jackson
| Sociétés | Poste | Début |
|---|---|---|
The Chartered Institute For Securities & Investment
 The Chartered Institute For Securities & Investment General GovernmentGovernment The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Redx Oncology Ltd.
 Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Directeur/Membre du Conseil | - |
Anciens postes connus de Dominic Nicholas Jackson
| Sociétés | Poste | Fin |
|---|---|---|
| REDX PHARMA PLC | Directeur Financier/CFO | 31/01/2019 |
Institute for Turnaround
 Institute for Turnaround Miscellaneous Commercial ServicesCommercial Services Institute for Turnaround operates as a non-profit organization. It engages in professional body for all those specialized and qualified individuals working in corporate sector. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REDX PHARMA PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
The Chartered Institute For Securities & Investment
The Chartered Institute For Securities & Investment General GovernmentGovernment The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom. | Government |
Institute for Turnaround
Institute for Turnaround Miscellaneous Commercial ServicesCommercial Services Institute for Turnaround operates as a non-profit organization. It engages in professional body for all those specialized and qualified individuals working in corporate sector. The company is headquartered in London, the United Kingdom. | Commercial Services |
Redx Oncology Ltd.
Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Health Technology |
